- Home
- DIN vs ENGN Comparison
DIN vs ENGN Comparison
Compare DIN & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIN
- ENGN
- Stock Information
- Founded
- DIN 1958
- ENGN 1999
- Country
- DIN United States
- ENGN Canada
- Employees
- DIN N/A
- ENGN N/A
- Industry
- DIN Restaurants
- ENGN
- Sector
- DIN Consumer Discretionary
- ENGN
- Exchange
- DIN Nasdaq
- ENGN Nasdaq
- Market Cap
- DIN 379.1M
- ENGN 321.5M
- IPO Year
- DIN 1991
- ENGN N/A
- Fundamental
- Price
- DIN $24.35
- ENGN $6.96
- Analyst Decision
- DIN Hold
- ENGN Buy
- Analyst Count
- DIN 9
- ENGN 8
- Target Price
- DIN $26.57
- ENGN $21.50
- AVG Volume (30 Days)
- DIN 543.2K
- ENGN 302.0K
- Earning Date
- DIN 11-05-2025
- ENGN 09-11-2025
- Dividend Yield
- DIN 8.38%
- ENGN N/A
- EPS Growth
- DIN N/A
- ENGN N/A
- EPS
- DIN 2.99
- ENGN N/A
- Revenue
- DIN $845,368,000.00
- ENGN N/A
- Revenue This Year
- DIN $11.28
- ENGN N/A
- Revenue Next Year
- DIN $2.11
- ENGN N/A
- P/E Ratio
- DIN $8.15
- ENGN N/A
- Revenue Growth
- DIN 2.92
- ENGN N/A
- 52 Week Low
- DIN $18.63
- ENGN $2.65
- 52 Week High
- DIN $37.44
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- DIN 59.44
- ENGN 81.05
- Support Level
- DIN $23.58
- ENGN $5.52
- Resistance Level
- DIN $24.96
- ENGN $6.54
- Average True Range (ATR)
- DIN 0.82
- ENGN 0.55
- MACD
- DIN 0.14
- ENGN 0.14
- Stochastic Oscillator
- DIN 75.30
- ENGN 96.80
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.